The obesity drug craze is entering its next p...

Economists gathered this week for the IMF and World Bank meetings amid soaring oil prices. In this Viewsroom podcast, Breakingviews columnists discuss how debt-laden countries face an impossible task of managing inflation, higher rates and defence demands while protecting voters. ...  Afficher plus

Whether it’s Kraft Heinz weighing a split of its ketchup and hot-dog units or Unilever sealing a $65 bln mayonnaise deal, edible empires are coming apart. In this week’s Viewsroom, Breakingviews columnists debate consumer groups’ sticky spot between ultra-budget and luxe rivals. ...  Afficher plus

Listen to the first episode of our new podcast. Host Carmel Crimmins and China bureau chief Kevin Krolicki discuss recent moves by the US to impose tariffs on China’s hot industry – EVs. What is protectionism versus good local policy, how have we arrived at this point, and what d ...  Afficher plus

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ...  Afficher plus

Riots rage in New Caledonia, as France approves changes to voting rules in the French territory. President Biden’s top economic adviser – Lael Brainard – joins the Reuters World News podcast for an interview, as the US hits China with steep tariffs. Plus, Secretary of State Anton ...  Afficher plus

Passengers are left shaken after severe turbulence hit a Singapore Airlines flight. Eli Lilly’s diabetes drug wins approval in China, intensifying weight loss drugmakers’ competition in the Asian market. And a Kenyan police deployment to Haiti to help combat gang violence is immi ...  Afficher plus